Χώρα: Ιρλανδία
Γλώσσα: Αγγλικά
Πηγή: HPRA (Health Products Regulatory Authority)
PERINDOPRIL TERT-BUTYLAMINE
Glenmark Pharmaceuticals Europe Limited
PERINDOPRIL TERT-BUTYLAMINE
2 Milligram
Tablets
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
February 2014 PACKAGE LEAFLET: INFORMATION FOR THE USER PERINDOPRIL 2MG TABLETS PERINDOPRIL 4MG TABLETS PERINDOPRIL 8MG TABLETS Perindopril tert-butylamine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Perindopril is and what is it used for 2. What you need to know before you take Perindopril Tablets 3. How to take Perindopril Tablets 4. Possible side effects. 5. How to store Perindopril Tablets 6. Contents of the pack and other information 1. WHAT PERINDOPRIL IS AND WHAT IT IS USED FOR PERINDOPRIL belongs to a group of medicines called ACE inhibitors. These work by widening the blood vessels. This makes it easier for your heart to pump blood through the body. Perindopril 2 mg or 4 mg tablets are used to: • treat high blood pressure (hypertension) • treat heart failure (a condition where the heart is unable to pump enough blood to meet the body’s needs) • reduce the risk of cardiac events, such as heart attack, in patients with stable coronary artery disease (a condition where the blood supply to the heart is reduced or blocked) and who have already had a heart attack and/or an operation to improve the blood supply to the heart by widening the vessels that supply it. Perindopril 8 mg Διαβάστε το πλήρες έγγραφο
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Prindex 2 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2 mg perindopril tert-butylamine salt, equivalent to 1.669 mg perindopril Excipient(s) with known effect: 31.39 mg of lactose monohydrate For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. White, round, biconvex tablet, smooth on both sides. Tablet dimensions: 5.00 ± 0.10mm 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertension: Treatment of hypertension Heart failure: Treatment of symptomatic heart failure Stable Coronary Artery Disease Reduction of risk of cardiac events in patients with a history of myocardial infarction and/or revascularisation 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Method of administration It is recommended that Prindex is taken once daily in the morning before a meal. The dose should be individualised according to the patient profile (see 4.4 “Special warnings and precautions for use”) and blood pressure response. Posology Hypertension Prindex may be used in monotherapy or in combination with other classes of antihypertensive therapy. The recommended starting dose is 4 mg given once daily in the morning. Patients with a strongly activated renin-angiotensin-aldosterone system (in particular, renovascular hypertension, salt and/or volume depletion, cardiac decompensation or severe hypertension) may experience an excessive drop in blood pressure following the initial dose. A starting dose of 2 mg is recommended in such patients and the initiation of treatment should take place under medical supervision. The dose may be increased to 8 mg once daily after one month of treatment. Symptomatic hypotension may occur following initiation of therapy with Perindopril; this is more lik Διαβάστε το πλήρες έγγραφο